- Home
- GAIN vs IMTX Comparison
GAIN vs IMTX Comparison
Compare GAIN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- IMTX
- Stock Information
- Founded
- GAIN 2005
- IMTX N/A
- Country
- GAIN United States
- IMTX Germany
- Employees
- GAIN N/A
- IMTX N/A
- Industry
- GAIN Finance: Consumer Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAIN Finance
- IMTX Health Care
- Exchange
- GAIN Nasdaq
- IMTX Nasdaq
- Market Cap
- GAIN 497.5M
- IMTX 559.1M
- IPO Year
- GAIN 2005
- IMTX N/A
- Fundamental
- Price
- GAIN $13.63
- IMTX $4.60
- Analyst Decision
- GAIN Hold
- IMTX Strong Buy
- Analyst Count
- GAIN 2
- IMTX 4
- Target Price
- GAIN $13.75
- IMTX $16.67
- AVG Volume (30 Days)
- GAIN 117.3K
- IMTX 1.2M
- Earning Date
- GAIN 02-12-2025
- IMTX 03-20-2025
- Dividend Yield
- GAIN 7.04%
- IMTX N/A
- EPS Growth
- GAIN N/A
- IMTX N/A
- EPS
- GAIN 1.92
- IMTX N/A
- Revenue
- GAIN $89,176,000.00
- IMTX $128,824,447.00
- Revenue This Year
- GAIN $6.13
- IMTX $116.22
- Revenue Next Year
- GAIN $8.54
- IMTX N/A
- P/E Ratio
- GAIN $7.11
- IMTX N/A
- Revenue Growth
- GAIN 6.78
- IMTX 52.53
- 52 Week Low
- GAIN $12.46
- IMTX $4.48
- 52 Week High
- GAIN $14.85
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- GAIN 53.04
- IMTX 27.20
- Support Level
- GAIN $13.26
- IMTX $4.85
- Resistance Level
- GAIN $13.64
- IMTX $5.25
- Average True Range (ATR)
- GAIN 0.18
- IMTX 0.28
- MACD
- GAIN 0.02
- IMTX -0.01
- Stochastic Oscillator
- GAIN 52.56
- IMTX 8.96
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.